Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00599079 · ClinicalTrials.gov registry record · Phase 4

Azithromycin in the Treatment of M. Avium Complex Lung Disease

A Phase 4 study, sponsored by The University of Texas Health Science Center at Tyler.

Completed
Registry status
Phase 4
Development phase
66
Enrollment target

NCT00599079: Completed Phase 4 study, sponsored by The University of Texas Health Science Center at Tyler.

NCT00599079 is a Phase 4 study that has completed, run by The University of Texas Health Science Center at Tyler. The registered enrollment target is 66 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00599079, a Phase 4 study, has completed, sponsored by The University of Texas Health Science Center at Tyler.

COMPLETED
Registry status
Phase 4
Development phase
66 participants
Enrollment target

Study Summary

To determine the safety and efficacy of azithromycin in the treatment of lung infection with M.avium complex and M. abscessus lung disease.

Primary Outcome

neg cultures X3( sputum conversion)

Interventions

  • DRUG Azithromycin

Trial Details

FieldValue
Enrollment Target 66 participants
Start Date 1993-02
Est. Completion 2017-05-18
Phase Phase 4

What the finished NCT00599079 record still lists

NCT00599079 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 66 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (87% lower).

The record links to 0 conditions, and to 1 intervention - of which Azithromycin is the first listed.

NCT00599079 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00599079 about?

NCT00599079 is a clinical study titled "Azithromycin in the Treatment of M. Avium Complex Lung Disease". To determine the safety and efficacy of azithromycin in the treatment of lung infection with M.avium complex and M. abscessus lung disease.

What is the current status of trial NCT00599079?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 66 participants. The study started on 1993-02. Estimated completion is 2017-05-18.

What interventions are being tested in trial NCT00599079?

The interventions under investigation include: Azithromycin (DRUG).

Who is sponsoring clinical trial NCT00599079?

This trial is sponsored by The University of Texas Health Science Center at Tyler, which has 7 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00599079's enrollment target sits among peer trials

66 1083rd of 2000 higher than 910 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02584244 · 66 participants · Phase 1

    Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers

  • NCT03067051 · 66 participants · Phase 1

    Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System

  • NCT03754725 · 66 participants · Phase 1

    Ferritin and Iron Burden in SAH sIRB

  • NCT03875378 · 66 participants · Phase 2

    Transdermal Estrogen in Women With Anorexia Nervosa

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00599079, the US trial registry maintained by the National Library of Medicine. NCT00599079 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.